Clinical effects of Irinotecan hydrochloride (cas 100286-90-6) in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
-
Add time:07/22/2019 Source:sciencedirect.com
ObjectiveTo evaluate the toxicity and efficacy of irinotecan plus cisplatin neoadjuvant chemotherapy (NACT) for cervical cancer.
We also recommend Trading Suppliers and Manufacturers of Irinotecan hydrochloride (cas 100286-90-6). Pls Click Website Link as below: cas 100286-90-6 suppliers
Prev:Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats
Next:Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoring) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan hydrochloride (cas 100286-90-6)07/26/2019
- Salvage chemotherapy with a combination of Irinotecan hydrochloride (cas 100286-90-6) and mitomycin C in elderly Japanese patients with gynecological malignancies: a pilot study07/25/2019
- Halloysite nanotubes as carriers for irinotecan: Synthesis and characterization by experimental and molecular simulation methods07/24/2019
- Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoring07/23/2019
- Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats07/20/2019
- Impact of diet on irinotecan toxicity in mice07/21/2019
- Active loading liposomal Irinotecan hydrochloride (cas 100286-90-6): Preparation, in vitro and in vivo evaluation07/19/2019
- Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride (cas 100286-90-6) in rat plasma by using high performance liquid chromatography-diode array detector07/18/2019
- A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of Irinotecan hydrochloride (cas 100286-90-6) liposome injection07/17/2019
-
Health and Chemical more >